Otlertuzumab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Otlertuzumab Biosimilar - Anti-CD37/TSPAN26 mAb - Research Grade

Description of Otlertuzumab Biosimilar - Anti-CD37/TSPAN26 mAb - Research Grade

General information on Anti-CD37/TSPAN26[Homo sapiens] (Otlertuzumab) Monoclonal Antibody

Otlertuzumab is investigated for the treatment of chronic lymphocytic leukemia.

Product nameOtlertuzumab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
SourceCAS 1372645-37-8
SpeciesHumanized
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTRU-016
ReferencePX-TA1343
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeVH-V-kappa-CH2-CH3
ClonalityMonoclonal Antibody
SourceCAS 1372645-37-8
Product nameOtlertuzumab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
SourceCAS 1372645-37-8
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTRU-016
ReferencePX-TA1343
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeVH-V-kappa-CH2-CH3
ClonalityMonoclonal Antibody
SourceCAS 1372645-37-8

Reviews

There are no reviews yet.

Be the first to review “Otlertuzumab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade”

Your email address will not be published.


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: